Thermo Fisher Scientific expands hematology oncology NGS portfolio
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Three Sysmex haemostasis analyzers are connectable to Inpeco’s FlexLab Total Laboratory Automation System
Automated blood coagulation analyzers CN-3500 and CN-6500 using chemiluminescence enzyme immunoassay (CLEIA) technology launched to enhance the testing workflow
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot-dissolving drug, which include bleeding on the brain
Top talks presenting the latest technologies, research and applications are now available on demand
Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
New service reduces project time from months to weeks for biopharma customers
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin